295 related articles for article (PubMed ID: 10941900)
1. The immunological effects of taxanes.
Chan OT; Yang LX
Cancer Immunol Immunother; 2000 Jul; 49(4-5):181-5. PubMed ID: 10941900
[TBL] [Abstract][Full Text] [Related]
2. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.
Tsavaris N; Kosmas C; Vadiaka M; Kanelopoulos P; Boulamatsis D
Br J Cancer; 2002 Jul; 87(1):21-7. PubMed ID: 12085250
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes.
Galletti E; Magnani M; Renzulli ML; Botta M
ChemMedChem; 2007 Jul; 2(7):920-42. PubMed ID: 17530726
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of the taxanes.
Dorr RT
Pharmacotherapy; 1997; 17(5 Pt 2):96S-104S. PubMed ID: 9322876
[TBL] [Abstract][Full Text] [Related]
6. Taxanes: a new class of antitumor agents.
Huizing MT; Misser VH; Pieters RC; ten Bokkel Huinink WW; Veenhof CH; Vermorken JB; Pinedo HM; Beijnen JH
Cancer Invest; 1995; 13(4):381-404. PubMed ID: 7627725
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 induction by paclitaxel, docetaxel, and taxane analogues in human monocytes and murine macrophages: structure-activity relationships and their implications.
Cassidy PB; Moos PJ; Kelly RC; Fitzpatrick FA
Clin Cancer Res; 2002 Mar; 8(3):846-55. PubMed ID: 11895918
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of paclitaxel and docetaxel in human neuroblastoma cell lines.
Riccardi A; Servidei T; Tornesello A; Puggioni P; Mastrangelo S; Rumi C; Riccardi R
Eur J Cancer; 1995; 31A(4):494-9. PubMed ID: 7576952
[TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
10. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
Shi B; Yaremko B; Hajian G; Terracina G; Bishop WR; Liu M; Nielsen LL
Cancer Chemother Pharmacol; 2000; 46(5):387-93. PubMed ID: 11127943
[TBL] [Abstract][Full Text] [Related]
11. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
Sparano JA
Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
[TBL] [Abstract][Full Text] [Related]
12. Lack of thermal enhancement for taxanes in vitro.
Rietbroek RC; Katschinski DM; Reijers MH; Robins HI; Geerdink A; Tutsch K; d'Oleire F; Haveman J
Int J Hyperthermia; 1997; 13(5):525-33. PubMed ID: 9354937
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways of taxanes-induced apoptosis.
Ganansia-Leymarie V; Bischoff P; Bergerat JP; Holl V
Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):291-306. PubMed ID: 12769774
[TBL] [Abstract][Full Text] [Related]
14. Taxanes: an overview of the pharmacokinetics and pharmacodynamics.
Vaishampayan U; Parchment RE; Jasti BR; Hussain M
Urology; 1999 Dec; 54(6A Suppl):22-9. PubMed ID: 10606281
[TBL] [Abstract][Full Text] [Related]
15. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
16. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors.
Ferlini C; Distefano M; Pignatelli F; Lin S; Riva A; Bombardelli E; Mancuso S; Ojima I; Scambia G
Br J Cancer; 2000 Dec; 83(12):1762-8. PubMed ID: 11104578
[TBL] [Abstract][Full Text] [Related]
17. Role of taxoids in head and neck cancer.
Schrijvers D; Vermorken JB
Oncologist; 2000; 5(3):199-208. PubMed ID: 10884498
[TBL] [Abstract][Full Text] [Related]
18. Taxanes in combined-modality therapy for solid tumors.
Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and docetaxel in prostate cancer.
Obasaju C; Hudes GR
Hematol Oncol Clin North Am; 2001 Jun; 15(3):525-45. PubMed ID: 11525295
[TBL] [Abstract][Full Text] [Related]
20. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
